Belanich M, Randall T, Pastor MA, Kibitel JT, Alas LG, Dolan ME, Schold SC,
Gander M, Lejeune FJ, Li BFL, White AB, Wasserman P, Citron ML and Yarosh
DB (1996b) Intracellular localization and intercellular heterogeneity of the human
DNA repair protein O6-methylguanine-DNA methyltransferase. Cancer Chemother Pharmacol 37:547–555.
Bodell JW, Aida T, Berger MS and Rosenblum ML (1985) Repair of O6-(2- chloroethyl)guanine mediates the biological effects of chloroethylnitrosoureas. Env
Health Persp 62:119 –126.
Bohr VA, Phillips DH and Hanawalt PC (1987) Heterogeneous DNA damage and
repair in the mammalian genome. Cancer Res 47:6426 – 6436.
Carter RD, Krementz ET, Hill GJ, Metter GE, Fletcher WS, Golomb FM, Grade TB,
Minton JP and Sparks FC (1976) DTIC (NSC-45388) and combination therapy for
melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037),
vincristine (NSC-67574) and hydroxyurea (NSC-32065). Cancer Treat Rep 60:601–
609.
Chen J, Zhang Y, Moschel RC and Ikenaga M (1993) Depletion of O6-methylguanineDNA methyltransferase and potentiation of 1,3-bis (2-chloroethyl)-1-nitrosourea
antitumor activity by O6-benzylguanine in vitro. Carcinogenesis 14:1057–1060.
Church KM, Wurdeman RL, Zhang Y, Chen F and Gold B (1990) N-(2-chloroethyl)- N-nitrosoureas covalently bound to nonionic and monocationic lexitropsin dipeptides. Synthesis, DNA affinity binding characteristics and reactions with 32P-endlabeled DNA. Biochemistry 29:6827– 6838.
Fairbairn LJ, Watson AJ, Rafferty JA, Elder RH and Marfison GP (1995) O6- benzylguanine increases the sensitivity of human primary bone marrow cells to
the cytotoxic effects of temozolomide. Exp Hematol 23:112–116.
Ford PG and Wang B (1993) The updated electrostatic potential for cytosine completes the qualitative explanations of base alkylation regiochemistry. Carcinogenesis 14:1465–1467.
Gibson NW, Hartley JA, Lafrance RJ and Vaughan K (1986) Differential cytotoxicity
and DNA-damaging effects produced in human cells of the Mer+ and Merphenotypes by a series of alkyltriazenylimidazoles. Carcinogenesis 2:259 –265.
Hartley JA, Mattes WB, Vaughan K and Gibson NW (1988) DNA sequence specificity
of guanine N7-alkylation for a series of structurally related triazenes. Carcinogenesis 9:669 – 674.
Hill GJ, Metter GE, Krementz ET, Fletcher WS, Golomb FM, Ramirez G, Grage TB
and Moss SE (1989) DTIC and combination therapy for melanoma. II. Escalating
schedules of DTIC with BCNU, CCNU and vincristine. Cancer Treat. Rep. 63:
1989 –1992.
Jean-Claude BJ (1992) Synthesis and spectral studies of tetrazepinones (McGill
University, Montreal), Ph.D. dissertation.
Jean-Claude BJ, Damian S, Damian Z, Do Khan L, Chan TH and Leyland-Jones B
(1994) Tetrazepinones: A new class of DNA-directed antitumor agents. Proc Am
Assoc Cancer Res 35:402.
Jean-Claude BJ, Mustafa A, Damian Z, De Marte J, Chan TH and Leyland-Jones B
(1995) Comparative studies on the action of Temozolomide and two novel tetrazepinones on OVCAR-3 cell line in vitro. Proc Am Assoc Cancer Res 36:349.
